Shahin Lockman; Hughes Michael; Sawe Fred; Yu Zheng; McIntyre James; Chipato Tsungai; Aida Asmelash; Mohammed Rassool; Shaffer Douglas; Mina Hosseinipour; Lerato Mohapi; Ssali Francis; Chibowa Margret; Amod Farida; Halvas Elias; Hogg Evelyn; Alston-Smith Beverly; Laura Smith; Schooley Robert; Mellors John; Currie Judith
(Journals.plos.org, 2012-06-12)
Background
Nevirapine (NVP) is widely used in antiretroviral treatment (ART) of HIV-1 globally. The primary objective of the AA5208/OCTANE trial was to compare the efficacy of NVP-based versus lopinavir/ritonavir ...